Hair Restoration—Nonsurgical and Surgical Approaches

      Androgenic alopecia is a common cause of hair loss in men and women, with increasing prevalence with age and a negative association with quality of life.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic and Personal


      Subscribe to Advances in Cosmetic Surgery
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Gan D.C.
        • Sinclair R.D.
        Prevalence of male and female pattern hair loss in Maryborough.
        J Investig Dermatol Symp Proc. 2005; 10: 184-189
        • RC S.
        A method for visually describing and quantitating hair loss in male pattern baldness.
        J Invest Dermatol. 1992; 98
        • Norwood O.T.
        Male pattern baldness: classification and incidence.
        South Med J. 1975; 68: 1359-1365
        • Gupta M.
        • Mysore V.
        Classifications of patterned hair loss: a review.
        J Cutan Aesthet Surg. 2016; 9: 3-12
        • Williamson D.
        • Gonzalez M.
        • Finlay A.Y.
        The effect of hair loss on quality of life.
        J Eur Acad Dermatol Venereol. 2001; 15: 137-139
        • Cash T.F.
        The psychosocial consequences of androgenetic alopecia: a review of the research literature.
        Br J Dermatol. 1999; 141: 398-405
        • Hunt N.
        • McHale S.
        The psychological impact of alopecia.
        BMJ. 2005; 331: 951-953
        • Semalty M.
        • Semalty A.
        • Joshi G.P.
        • et al.
        Hair growth and rejuvenation: an overview.
        J Dermatolog Treat. 2011; 22: 123-132
      1. Value of the hair loss treatment market worldwide in 2010 and 2017. Health and Pharmaceuticals > State of Health 2017. Accessed August 16, 2019.

        • Olsen E.A.
        • Whiting D.
        • Bergfeld W.
        • et al.
        A multicenter, randomized, placebo-controlled, double-blind clinical trial of a novel formulation of 5% minoxidil topical foam versus placebo in the treatment of androgenetic alopecia in men.
        J Am Acad Dermatol. 2007; 57: 767-774
        • Goodman P.J.
        • Tangen C.M.
        • Darke A.K.
        • et al.
        Long-term effects of finasteride on prostate cancer mortality.
        N Engl J Med. 2019; 380: 393-394
        • Unger J.M.
        • Hershman D.L.
        • Till C.
        • et al.
        Using medicare claims to examine long-term prostate cancer risk of finasteride in the prostate cancer prevention trial.
        J Natl Cancer Inst. 2018; 110: 1208-1215
        • Olsen E.A.
        • Whiting D.A.
        • Savin R.
        • et al.
        Global photographic assessment of men aged 18 to 60 years with male pattern hair loss receiving finasteride 1 mg or placebo.
        J Am Acad Dermatol. 2012; 67: 379-386
        • Zhou Z.
        • Song S.
        • Gao Z.
        • et al.
        The efficacy and safety of dutasteride compared with finasteride in treating men with androgenetic alopecia: a systematic review and meta-analysis.
        Clin Interv Aging. 2019; 14: 399-406
        • Shanshanwal S.J.
        • Dhurat R.S.
        Superiority of dutasteride over finasteride in hair regrowth and reversal of miniaturization in men with androgenetic alopecia: a randomized controlled open-label, evaluator-blinded study.
        Indian J Dermatol Venereol Leprol. 2017; 83: 47-54
        • Won Y.Y.
        • Lew B.L.
        • Sim W.Y.
        Clinical efficacy of oral administration of finasteride at a dose of 2.5 mg/day in women with female pattern hair loss.
        Dermatol Ther. 2018; 31: e12588
        • Sinclair R.
        • Wewerinke M.
        • Jolley D.
        Treatment of female pattern hair loss with oral antiandrogens.
        Br J Dermatol. 2005; 152: 466-473
        • Sinclair R.D.
        Female pattern hair loss: a pilot study investigating combination therapy with low-dose oral minoxidil and spironolactone.
        Int J Dermatol. 2018; 57: 104-109
        • Leavitt M.
        • Charles G.
        • Heyman E.
        • et al.
        HairMax LaserComb laser phototherapy device in the treatment of male androgenetic alopecia: a randomized, double-blind, sham device-controlled, multicentre trial.
        Clin Drug Investig. 2009; 29: 283-292
        • Jimenez J.J.
        • Wikramanayake T.C.
        • Bergfeld W.
        • et al.
        Efficacy and safety of a low-level laser device in the treatment of male and female pattern hair loss: a multicenter, randomized, sham device-controlled, double-blind study.
        Am J Clin Dermatol. 2014; 15: 115-127
        • Gupta A.K.
        • Carviel J.L.
        Meta-analysis of efficacy of platelet-rich plasma therapy for androgenetic alopecia.
        J Dermatolog Treat. 2017; 28: 55-58
        • Hausauer A.K.
        • Jones D.H.
        Evaluating the efficacy of different platelet-rich plasma regimens for management of androgenetic alopecia: a single-center, blinded, randomized clinical trial.
        Dermatol Surg. 2018; 44: 1191-1200
        • Sharma V.K.
        • Bhari N.
        • Patra S.
        • et al.
        Platelet-rich plasma therapy for androgenetic alopecia.
        Indian J Dermatol. 2019; 64: 417-419
        • Rose P.T.
        • Nusbaum A.G.
        • Nusbaum B.P.
        • et al.
        A comparison of apoptotic activity for follicular unit extraction hair grafts stored in different holding solutions.
        Dermatol Surg. 2020; 46: 721-723
        • Kerure A.S.
        • Patwardhan N.
        Complications in hair transplantation.
        J Cutan Aesthet Surg. 2018; 11: 182-189
        • Nadimi S.
        Complications with hair transplantation.
        Facial Plast Surg Clin North Am. 2020; 28: 225-235
        • Vano-Galvan S.
        • Jaen P.
        Practical manual of trichology.
        Hair Transplant. 2019;